Company ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Equities
1541
CNE100006624
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.58 HKD | -2.15% | -1.09% | -51.24% |
Business Summary
Number of employees: 145
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cell Strain and Other Products
95.1
%
| 1 | 92.8 % | 0 | 95.1 % | -30.11% |
Testing Services
4.9
%
| 0 | 7.2 % | 0 | 4.9 % | -53.71% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -31.82% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wen Zhi Tian
CEO | Chief Executive Officer | - | 15-05-31 |
Qi Ying Lu
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 15-11-30 |
Zikai Xiong
PRN | Corporate Officer/Principal | - | 22-02-28 |
Ru liang Zhang
PRN | Corporate Officer/Principal | - | 17-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Tat Yeung
BRD | Director/Board Member | 55 | - |
Zhi Hua Yu
BRD | Director/Board Member | 56 | - |
Wen Zhi Tian
CEO | Chief Executive Officer | - | 15-05-31 |
Zhenping Zhu
BRD | Director/Board Member | - | - |
Xiao Yong Yu
BRD | Director/Board Member | 51 | - |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 15-11-30 |
Cong Xu
BRD | Director/Board Member | - | - |
Kendall Smith
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 228,550,039 | 69,612,628 ( 30.46 %) | 0 | 30.46 % |
Company contact information
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.
Building 15, Lane 1000 Zhangheng Road
200120, Zhangjiang Science City
+86 21 3801 6387
http://cn.immuneonco.comSector
Sales per Business
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.24% | 713M | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- 1541 Stock
- Company ImmuneOnco Biopharmaceuticals (Shanghai) Inc.